Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Pharma/Biotech
Recent news which mentions Pharma/Biotech
< Previous
1
2
...
26
27
28
29
30
31
32
33
Next >
XBI Biotech 15% Potential
February 08, 2022
Tickers
XBI
Tags
Pharma/Biotech
Market News
ETFs
From
TalkMarkets
The Canadian Cannabis Report- Monday, Feb. 7
February 07, 2022
Tickers
CNBS
FLWPF
HEXO
MJ
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
Psychedelic Stocks Finally In An Upswing
February 06, 2022
Tickers
ATAI
CYBN
DMTTF
FTRP
Tags
Market News
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, & More
February 06, 2022
Tickers
ABBV
AVRO
BIIB
LOGC
Tags
Pharma/Biotech
Stocks / Equities
Healthcare
From
TalkMarkets
Week In Review: Biopharma Deals Slow During Chinese New Year Week
February 05, 2022
Tickers
BNIGF
HCM
XVIPF
Tags
Market News
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
Market Briefing For Thursday, Feb. 3
February 03, 2022
Tickers
AMD
FB
QQQ
SPOT
Tags
Market News
Consumer Goods
Stocks / Equities
From
TalkMarkets
Is Novavax Turning Around? A Technical Analysis
February 01, 2022
Tickers
NVAX
Tags
Stocks / Equities
Pharma/Biotech
Market News
From
TalkMarkets
Tuesday Talk: Who's Got The Rebound?
February 01, 2022
Tickers
ABBV
ADM
IWM
QQQ
Tags
Consumer Goods
Market News
Technology
From
TalkMarkets
Has A Sugar Daddy Emerged In The Psychedelic Drug Industry?
January 31, 2022
Tickers
ATAI
AWKNF
CMPS
MSSTF
Tags
Market News
Pharma/Biotech
Stocks / Equities
From
TalkMarkets
Small Cap Biotech Stocks: Is it time to start trading?
January 31, 2022
Tickers
ABBV
ARKG
BMY
IBB
Tags
Stocks / Equities
Pharma/Biotech
Market News
From
TalkMarkets
The Canadian Cannabis Report- Monday Jan. 31
January 31, 2022
Tickers
ACB
CNBS
MJ
NEPT
Tags
Market News
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
The Psychedelic & Marijuana Drug Stocks Index Dropped -30% In January
January 30, 2022
Tickers
ALID
ATAI
AWKNF
CMPS
Tags
Market News
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
Should We Start Watching Noncyclical Stocks?
January 30, 2022
Tickers
DIA
IWM
LEVI
SPY
Tags
Market News
Consumer Goods
Stocks / Equities
From
TalkMarkets
Week In Review: Xbiome Acquires Diabetic Foot Ulcer Therapy In $139 Million Deal
January 29, 2022
Tickers
CRSP
IMAB
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
Market Briefing For Wednesday, Jan. 26
January 26, 2022
Tickers
MSFT
PFE
SRNE
TXN
Tags
Market News
Technology
Pharma/Biotech
From
TalkMarkets
The Canadian Cannabis Report- Monday, Jan. 24
January 24, 2022
Tickers
ACB
ALEAF
CBWTF
CGC
Tags
Market News
Pharma/Biotech
Stocks / Equities
From
TalkMarkets
Weekend Update: Only 2 Psychedelic Drug Stocks Are Up YTD
January 23, 2022
Tickers
ATAI
CMPS
CRBP
CYBN
Tags
Market News
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
The Week Ahead In Biotech (Jan. 23-29): Roche, Azurity FDA Decisions, J&J, Vertex Earnings, & More
January 23, 2022
Tickers
ABT
CUE
DCPH
ETON
Tags
Market News
Healthcare
Pharma/Biotech
From
TalkMarkets
Do You Have A Solid Trading Plan?
January 23, 2022
Tickers
DBA
DIA
IBB
IWM
Tags
Transportation
ETFs
Energy
From
TalkMarkets
Week In Review: Mabwell Bio Raises $547 Million In Shanghai STAR IPO
January 22, 2022
Tickers
LLY
Tags
Market News
Pharma/Biotech
Stocks / Equities
From
TalkMarkets
Forex Today: Stocks Fall As US Treasury Yields Spike
January 19, 2022
Tickers
BITCOMP
PFE
SPTL
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
3 Pharma Stocks Yielding Over 3%
January 18, 2022
Tickers
AMGN
BMY
MRK
XBI
Tags
Market News
Pharma/Biotech
Stocks / Equities
From
TalkMarkets
The Canadian Cannabis Report- Monday, Jan. 17
January 17, 2022
Tickers
CNBS
FLWPF
MJ
NEPT
Tags
Market News
Pharma/Biotech
Stocks / Equities
From
TalkMarkets
The Week Ahead In Biotech (Jan. 16-22): Focus On Data Presentations And IPOs In Holiday-Shortened Week
January 16, 2022
Tickers
ALNY
ASLN
AZN
CRDF
Tags
Healthcare
Market News
Stocks / Equities
From
TalkMarkets
Is The Market Falling Into A Rangebound Trap?
January 16, 2022
Tickers
BITCOMP
IWM
IYT
KRE
Tags
Transportation
ETFs
Cryptocurrencies
From
TalkMarkets
Marijuana & Psychedelic Drug Stocks Continue To Decline
January 16, 2022
Tickers
ALID
CRBP
DMTTF
FTRP
Tags
Market News
Pharma/Biotech
Stocks / Equities
From
TalkMarkets
Illumina Jumps As Gene Sequencing Demand Drives Stronger Outlook
January 11, 2022
Tickers
ILMN
PACB
UNH
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
Tuesday Talk: Slipping On Rate Hike Ice
January 11, 2022
Tickers
AN
BBY
BWA
DHI
Tags
Market News
Consumer Goods
Healthcare
From
TalkMarkets
The Canadian Cannabis Report - Monday, Jan. 10
January 10, 2022
Tickers
ALEAF
BHHKF
CNBS
DLTNF
Tags
Market News
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
Pure-Play Marijuana- & Psychedelic Compounds-Based Drug Stocks Index Is Down By 66% From 2021 High
January 09, 2022
Tickers
CRBP
CYBN
DMTTF
FTRP
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
< Previous
1
2
...
26
27
28
29
30
31
32
33
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.